Furthermore, tumor-infiltrating neutrophils could stimulate the invasion of macrophages and Tregs into the TME via the production of monocyte chemotactic protein 1, leading to the progression of HCC and resistance to sorafenib (51). This evidence concerns the gene CCL2 and hepatocellular carcinoma.